Reduced expression of HLA-DR on monocytes during severe respiratory syncytial virus infections

Pediatric Infectious Disease Journal

Volumn 35, Issue 3, 2016, Pages e89-e96

  Ahout, Inge M L ^a   Jans, Jop ^a   Haroutiounian, Lilid ^a   Simonetti, Elles R ^a   Van Der Gaast De Jongh, Christa ^a   Diavatopoulos, Dimitri A ^a   De Jonge, Marien I ^a   De Groot, Ronald ^a   Ferwerda, Gerben ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

CD14; Disease severity; Human leukocyte antigen DR; Innate immunity; Monocyte; Respiratory syncytial viruS

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR; BIOLOGICAL MARKER;

ANTIGEN EXPRESSION; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOPHENOTYPING; IN VITRO STUDY; INFANT; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PHYSICAL DISEASE; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL VIRUS INFECTION; BIOSYNTHESIS; CASE CONTROL STUDY; COHORT ANALYSIS; GENE EXPRESSION; GENETICS; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IMMUNOLOGY; LEUKOCYTE COUNT; METABOLISM; MONONUCLEAR CELL; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RISK FACTOR; SEVERITY OF ILLNESS INDEX; VIROLOGY;

BIOMARKERS; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GENE EXPRESSION; HLA-DR ANTIGENS; HUMANS; IMMUNOPHENOTYPING; INFANT; INTERLEUKIN-10; LEUKOCYTE COUNT; LEUKOCYTES, MONONUCLEAR; MALE; MONOCYTES; PHENOTYPE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84959235357     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000001007     Document Type: Article

References (41)

1. Nair H, Nokes DJ, Gessner BD, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010;375:1545-1555.
2. Hall CB, Weinberg GA, Iwane MK, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009;360:588-598.
3. James KM, Gebretsadik T, Escobar GJ, et al. Risk of childhood asthma following infant bronchiolitis during the respiratory syncytial virus season. J Allergy Clin Immunol. 2013;132:227-229.
4. Tregoning JS, Schwarze J. Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology. Clin Microbiol Rev. 2010;23:74-98.
5. Serbina NV, Jia T, Hohl TM, et al. Monocyte-mediated defense against microbial pathogens. Annu Rev Immunol. 2008;26:421-452.
6. Yang J, Zhang L, Yu C, et al. Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases. Biomark Res. 2014;2:1.
7. Wong KL, Yeap WH, Tai JJ, et al. The three human monocyte subsets: implications for health and disease. Immunol Res. 2012;53:41-57.
8. Ziegler-Heitbrock L, Ancuta P, Crowe S, et al. Nomenclature of monocytes and dendritic cells in blood. Blood. 2010;116:e74-e80.
9. Genel F, Atlihan F, Ozsu E, et al. Monocyte HLA-DR expression as predictor of poor outcome in neonates with late onset neonatal sepsis. J Infect. 2010;60:224-228.
10. Lekkou A, Karakantza M, Mouzaki A, et al. Cytokine production and monocyte HLA-DR expression as predictors of outcome for patients with community-acquired severe infections. Clin Diagn Lab Immunol. 2004;11: 161-167.
11. Monneret G, Lepape A, Voirin N, et al. Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med. 2006;32:1175-1183.
12. Midulla F, Huang YT, Gilbert IA, et al. Respiratory syncytial virus infection of human cord and adult blood monocytes and alveolar macrophages. Am Rev Respir Dis. 1989;140:771-777.
13. Schijf MA, Lukens MV, Kruijsen D, et al. Respiratory syncytial virus induced type I IFN production by pDC is regulated by RSV-infected airway epithelial cells, RSV-exposed monocytes and virus specific antibodies. PLoS One. 2013;8:e81695.
14. Soukup JM, Becker S. Role of monocytes and eosinophils in human respiratory syncytial virus infection in vitro. Clin Immunol. 2003;107:178-185.
15. Goritzka M, Makris S, Kausar F, et al. Alveolar macrophage-derived type I interferons orchestrate innate immunity to RSV through recruitment of antiviral monocytes. J Exp Med. 2015;212:699-714.
16. Collins PL, Graham BS. Viral and host factors in human respiratory syncytial virus pathogenesis. J Virol. 2008;82:2040-2055.
17. Kaneko M, Watanabe J, Ueno E, et al. Risk factors for severe respiratory syncytial virus-associated lower respiratory tract infection in children. Pediatr Int. 2001;43:489-492.
18. van den Kieboom CH, Ahout IM, Zomer A, et al. Nasopharyngeal gene expression, a novel approach to study the course of respiratory syncytial virus infection. Eur Respir J. 2015;45:718-725.
19. Brand HK, Ferwerda G, Preijers F, et al. CD4+ T-cell counts and interleukin- 8 and CCL-5 plasma concentrations discriminate disease severity in children with RSV infection. Pediatr Res. 2013;73:187-193.
20. Fingerle G, Pforte A, Passlick B, et al. The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients. Blood. 1993;82:3170-3176.
21. Ziegler-Heitbrock L. The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol. 2007;81:584-592.
22. Wong KL, Tai JJ, Wong WC, et al. Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood. 2011;118:e16-e31.
23. Zawada AM, Rogacev KS, Rotter B, et al. Super SAGE evidence for CD14++CD16+ monocytes as a third monocyte subset. Blood. 2011;118:e50-e61.
24. Evans HG, Gullick NJ, Kelly S, et al. In vivo activated monocytes from the site of inflammation in humans specifically promote Th17 responses. Proc Natl Acad Sci U S A. 2009;106:6232-6237.
25. Maus U, Herold S, Muth H, et al. Monocytes recruited into the alveolar air space of mice show a monocytic phenotype but upregulate CD14. Am J Physiol Lung Cell Mol Physiol. 2001;280:L58-L68.
26. Maus UA, Janzen S, Wall G, et al. Resident alveolar macrophages are replaced by recruited monocytes in response to endotoxin-induced lung inflammation. Am J Respir Cell Mol Biol. 2006;35:227-235.
27. Rolland A, Jouvin-Marche E, Viret C, et al. The envelope protein of a human endogenous retrovirus-W family activates innate immunity through CD14/TLR4 and promotes Th1-like responses. J Immunol. 2006;176:7636-7644.
28. Tundup S, Srivastava L, Harn DA Jr. Polarization of host immune responses by helminth-expressed glycans. Ann N Y Acad Sci. 2012;1253:E1-E13.
29. Hall MW, Knatz NL, Vetterly C, et al. Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome. Intensive Care Med. 2011;37:525-532.
30. Döcke WD, Randow F, Syrbe U, et al. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med. 1997;3:678-681.
31. Connolly J, Xu C, Guo H, et al. Respiratory syncytial virus blocks MHC Class-II surface translocation in human dendritic cells. Clinical Immunology. 2008;127:S33.
32. Rohwedder A, Keminer O, Forster J, et al. Detection of respiratory syncytial virus RNA in blood of neonates by polymerase chain reaction. J Med Virol. 1998;54:320-327.
33. Pinto RA, Arredondo SM, Bono MR, et al. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol. Pediatrics. 2006;117:e878-e886.
34. Le Tulzo Y, Pangault C, Amiot L, et al. Monocyte human leukocyte antigen-DR transcriptional downregulation by cortisol during septic shock. Am J Respir Crit Care Med. 2004;169:1144-1151.
35. Mejias A, Dimo B, Suarez NM, et al. Whole blood gene expression profiles to assess pathogenesis and disease severity in infants with respiratory syncytial virus infection. PLoS Med. 2013;10:e1001549.
36. Mella C, Suarez-Arrabal MC, Lopez S, et al. Innate immune dysfunction is associated with enhanced disease severity in infants with severe respiratory syncytial virus bronchiolitis. J Infect Dis. 2013;207:564-573.
37. Wolk K, Döcke W, von Baehr V, et al. Comparison of monocyte functions after LPS- or IL-10-induced reorientation: importance in clinical immunoparalysis. Pathobiology. 1999;67:253-256.
38. Murai H, Terada A, Mizuno M, et al. IL-10 and RANTES are elevated in nasopharyngeal secretions of children with respiratory syncytial virus infection. Allergol Int. 2007;56:157-163.
39. Bont L, Heijnen CJ, Kavelaars A, et al. Monocyte IL-10 production during respiratory syncytial virus bronchiolitis is associated with recurrent wheezing in a one-year follow-up study. Am J Respir Crit Care Med. 2000;161:1518-1523.
40. Loebbermann J, Schnoeller C, Thornton H, et al. IL-10 regulates viral lung immunopathology during acute respiratory syncytial virus infection in mice. PLoS One. 2012;7:e32371.
41. Weiss KA, Christiaansen AF, Fulton RB, et al. Multiple CD4+ T cell subsets produce immunomodulatory IL-10 during respiratory syncytial virus infection. J Immunol. 2011;187:3145-3154.